Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Rifaximin for Prevention of Travelers' Diarrhea
NCT00328380Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in traveler's diarrhea (TD), sponsored by Valeant Pharmaceuticals. Started Dec 2005; status: completed.
02
Drugs
rifaximin
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00328380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328380.